Antisense Therapeutics Limited (AU:PER) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Percheron Therapeutics Limited has announced a proposed issuance of 135,231,746 ordinary fully paid securities, aimed at boosting its capital. This strategic move is set to take place on October 24, 2024, potentially increasing the company’s market presence and attracting investors. Such placements are often seen as opportunities for growth and expansion within the financial markets.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.